All NewsEducationTV
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Brazilian police accuse Goldman Sachs executives of fraud

Created at 10 Aug · 11:03 PM1 source↑ Market-relevant
IN SHORT

Sao Paulo civil police have formally accused two Goldman Sachs representatives of fraud in a dispute over a public share tender offer for minority shareholders of cancer treatment group Oncoclinicas. The bank denies the allegations.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

Sao Paulo civil police
accused Goldman Sachs representatives of fraud
Goldman Sachs
denies allegations of fraud
Oncoclinicas
cancer treatment group involved in tender offer dispute
CVM
Brazil's securities regulator
B3
the stock exchange
Brazilian police accuse Goldman Sachs executives of fraud

↳ Why This Matters

The accusations of fraud against Goldman Sachs executives by Brazilian police highlight potential misconduct in corporate tender offers and could impact investor confidence in the financial institution and the Brazilian market.

Key facts

  • Sao Paulo civil police have formally accused two Goldman Sachs representatives of fraud.
  • The accusations stem from a dispute over a public share tender offer for Oncoclinicas minority shareholders.
  • Executives allegedly concealed ownership details and executed transactions to avoid triggering a mandatory tender offer.
  • Goldman Sachs denies the allegations, stating it acted appropriately.
  • The police filing alleges the information was used to block a tender offer to the detriment of minority shareholders.

Sao Paulo civil police have formally accused two Goldman Sachs representatives of fraud in a dispute concerning a public share tender offer for minority shareholders of the cancer treatment group Oncoclinicas. According to a police document seen by Reuters, the executives allegedly concealed ownership details in public filings and conducted transactions to transfer shares without triggering a mandatory tender offer, thereby deceiving minority shareholders and causing them losses.

Goldman Sachs has refuted the accusations, stating in a statement that it continues to believe it acted appropriately. Oncoclinicas declined to comment on the matter.

The police filing further alleges that Goldman Sachs reviewed information and presented a new version only when corporate restructuring threatened to trigger a mandatory tender offer, contradicting previous statements made to the market. The information, according to the police, was used to persuade Oncoclinicas, Brazil's securities regulator (CVM), the stock exchange (B3), and shareholders that the tender offer was not necessary, ultimately preventing the offer and harming minority shareholders.

Frequently asked questions

The executives are accused of fraud for allegedly concealing ownership details and executing transactions to avoid a mandatory tender offer, deceiving minority shareholders and causing them losses.

Goldman Sachs has stated that the allegations are unfounded and that the bank believes it acted appropriately.

The dispute involves Oncoclinicas, a Brazilian cancer treatment group.

What Happens Next

01Further legal proceedings or investigations may follow.
02The CVM and B3 may review their oversight processes.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

Brazilian police accused two Goldman Sachs representatives of fraud.
The executives allegedly concealed ownership details and transferred shares to avoid a mandatory tender offer.
Goldman Sachs stated the allegations were unfounded and that it acted appropriately.
The police filing claims the information was used to convince regulators and shareholders that a tender offer was not required.

Sources

T1
Brazilian police accuse Goldman executives of fraud over Oncoclinicas tender offerReuters

Related Stories

Natura posts 92% drop in Q2 net profit amid financial and operational woes
10 Aug · 11:32 PM
JBS to name Wesley Batista Filho as new global CEO
10 Aug · 6:34 PM
GameStop considering withdrawal of eBay takeover bid
10 Aug · 12:03 PM
Delaware judge orders Verisk to proceed with $2.35 billion AccuLynx deal
10 Aug · 10:40 AM
Blackstone's Safe Harbor Marinas Nears $1.5 Billion Deal for MarineMax
10 Aug · 11:09 AM